Matthew Bradford Bevers, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Edema | 7 | 2023 | 603 | 2.140 |
Why?
|
Heart Arrest | 5 | 2023 | 1506 | 1.020 |
Why?
|
Calpain | 4 | 2010 | 145 | 1.000 |
Why?
|
Brain Ischemia | 7 | 2023 | 3127 | 0.960 |
Why?
|
Subarachnoid Hemorrhage | 4 | 2021 | 1032 | 0.910 |
Why?
|
Stroke | 11 | 2023 | 9945 | 0.700 |
Why?
|
Brain Death | 1 | 2023 | 356 | 0.700 |
Why?
|
Embolectomy | 1 | 2018 | 129 | 0.570 |
Why?
|
Hypothermia, Induced | 2 | 2020 | 758 | 0.550 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2022 | 2776 | 0.520 |
Why?
|
Neurologic Examination | 1 | 2018 | 916 | 0.510 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2016 | 150 | 0.440 |
Why?
|
Brain Diseases | 1 | 2018 | 1540 | 0.330 |
Why?
|
Hydrocephalus | 1 | 2016 | 763 | 0.330 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2009 | 143 | 0.320 |
Why?
|
Glyburide | 2 | 2019 | 114 | 0.310 |
Why?
|
Hypoglycemia | 1 | 2016 | 888 | 0.310 |
Why?
|
N-Methylaspartate | 1 | 2009 | 231 | 0.310 |
Why?
|
Hippocampus | 2 | 2010 | 3737 | 0.280 |
Why?
|
Brain Injuries | 3 | 2022 | 2044 | 0.260 |
Why?
|
Cerebral Infarction | 2 | 2021 | 982 | 0.250 |
Why?
|
Electroencephalography | 2 | 2022 | 6182 | 0.230 |
Why?
|
Nerve Degeneration | 1 | 2007 | 748 | 0.220 |
Why?
|
Cell Survival | 2 | 2010 | 5796 | 0.210 |
Why?
|
Cerebral Hemorrhage | 3 | 2022 | 2660 | 0.200 |
Why?
|
Mannitol | 1 | 2022 | 180 | 0.200 |
Why?
|
Edema | 2 | 2023 | 772 | 0.200 |
Why?
|
Dependent Ambulation | 1 | 2021 | 12 | 0.190 |
Why?
|
Endothelin-1 | 1 | 2022 | 302 | 0.180 |
Why?
|
Decompressive Craniectomy | 1 | 2021 | 76 | 0.180 |
Why?
|
Delphi Technique | 1 | 2024 | 824 | 0.180 |
Why?
|
Factor VIIa | 1 | 2021 | 103 | 0.180 |
Why?
|
Neurons | 2 | 2010 | 9416 | 0.170 |
Why?
|
Inflammation | 1 | 2019 | 10757 | 0.170 |
Why?
|
Galectin 3 | 1 | 2020 | 240 | 0.160 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2022 | 352 | 0.150 |
Why?
|
Hematoma | 1 | 2022 | 769 | 0.150 |
Why?
|
Neuroprotective Agents | 2 | 2018 | 961 | 0.150 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2021 | 485 | 0.150 |
Why?
|
Water | 2 | 2023 | 1402 | 0.140 |
Why?
|
Mobility Limitation | 1 | 2021 | 402 | 0.140 |
Why?
|
Immunity | 1 | 2022 | 998 | 0.140 |
Why?
|
Thrombectomy | 1 | 2021 | 707 | 0.130 |
Why?
|
Cerebrospinal Fluid | 1 | 2019 | 544 | 0.130 |
Why?
|
Receptors, IgG | 1 | 2019 | 565 | 0.130 |
Why?
|
Cerebral Revascularization | 1 | 2017 | 249 | 0.120 |
Why?
|
Disability Evaluation | 2 | 2021 | 1826 | 0.120 |
Why?
|
North America | 1 | 2018 | 1282 | 0.120 |
Why?
|
Retrospective Studies | 9 | 2022 | 80301 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 2 | 2022 | 36247 | 0.100 |
Why?
|
Humans | 26 | 2024 | 760261 | 0.100 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15273 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1380 | 0.100 |
Why?
|
Metabolomics | 1 | 2021 | 1626 | 0.100 |
Why?
|
Recovery of Function | 2 | 2021 | 2982 | 0.100 |
Why?
|
Critical Care | 1 | 2024 | 2699 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2021 | 3207 | 0.090 |
Why?
|
Choline | 2 | 2023 | 513 | 0.090 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1882 | 0.090 |
Why?
|
RNA, Small Interfering | 2 | 2010 | 3443 | 0.090 |
Why?
|
Monocytes | 1 | 2019 | 2574 | 0.090 |
Why?
|
Middle Aged | 10 | 2021 | 220175 | 0.080 |
Why?
|
Clinical Competence | 1 | 2024 | 4786 | 0.080 |
Why?
|
Male | 14 | 2023 | 359413 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1819 | 0.080 |
Why?
|
CA1 Region, Hippocampal | 1 | 2008 | 109 | 0.080 |
Why?
|
Prognosis | 3 | 2023 | 29636 | 0.070 |
Why?
|
Female | 13 | 2023 | 391011 | 0.070 |
Why?
|
Aged | 9 | 2023 | 168995 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20484 | 0.070 |
Why?
|
Electrophysiology | 1 | 2010 | 1265 | 0.070 |
Why?
|
Dipeptides | 1 | 2008 | 410 | 0.070 |
Why?
|
Treatment Outcome | 4 | 2021 | 64947 | 0.070 |
Why?
|
Pyramidal Cells | 1 | 2008 | 369 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 2473 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2010 | 1697 | 0.060 |
Why?
|
Dependovirus | 1 | 2010 | 708 | 0.060 |
Why?
|
Rats | 3 | 2010 | 23695 | 0.060 |
Why?
|
Time Factors | 4 | 2021 | 40133 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2010 | 18968 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14656 | 0.050 |
Why?
|
Betaine | 1 | 2023 | 89 | 0.050 |
Why?
|
Protein Transport | 1 | 2009 | 1966 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14482 | 0.050 |
Why?
|
Embryo, Mammalian | 1 | 2009 | 1667 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 25928 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12156 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8595 | 0.050 |
Why?
|
Carnitine | 1 | 2023 | 251 | 0.050 |
Why?
|
Brain | 3 | 2023 | 26912 | 0.050 |
Why?
|
Osmolar Concentration | 1 | 2022 | 662 | 0.050 |
Why?
|
Physician Assistants | 1 | 2024 | 188 | 0.050 |
Why?
|
Water-Electrolyte Balance | 1 | 2022 | 334 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2019 | 22041 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2010 | 6242 | 0.050 |
Why?
|
RNA Interference | 1 | 2010 | 2846 | 0.050 |
Why?
|
Blood Glucose | 1 | 2016 | 6375 | 0.050 |
Why?
|
Gluconates | 1 | 2020 | 31 | 0.050 |
Why?
|
Receptors, Peptide | 1 | 2022 | 279 | 0.050 |
Why?
|
Transfection | 1 | 2009 | 5782 | 0.050 |
Why?
|
Receptors, Interleukin-1 | 1 | 2021 | 261 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2010 | 3378 | 0.040 |
Why?
|
Creatine | 1 | 2022 | 426 | 0.040 |
Why?
|
Aspartic Acid | 1 | 2022 | 576 | 0.040 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2020 | 296 | 0.040 |
Why?
|
Fibroblasts | 1 | 2009 | 4091 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15827 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17766 | 0.040 |
Why?
|
Animals | 5 | 2022 | 167940 | 0.030 |
Why?
|
Consciousness | 1 | 2022 | 601 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2009 | 4409 | 0.030 |
Why?
|
Prospective Studies | 2 | 2022 | 54263 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2018 | 58947 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2018 | 597 | 0.030 |
Why?
|
Uric Acid | 1 | 2020 | 807 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3106 | 0.030 |
Why?
|
Metabolome | 1 | 2021 | 976 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2009 | 12762 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3764 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2021 | 6543 | 0.020 |
Why?
|
Risk Factors | 1 | 2018 | 74269 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 11902 | 0.020 |
Why?
|
Adult | 3 | 2020 | 219847 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8553 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2017 | 2108 | 0.020 |
Why?
|
Rats, Long-Evans | 1 | 2008 | 373 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12412 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7345 | 0.020 |
Why?
|
Random Allocation | 1 | 2008 | 2394 | 0.010 |
Why?
|
Blotting, Western | 1 | 2008 | 5039 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41317 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23363 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10829 | 0.010 |
Why?
|
United States | 1 | 2024 | 72363 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11064 | 0.010 |
Why?
|